Cell Cycle Analysis Market Emerging Trends, Latest Innovations and Technological Growth Report 2018 by Its Clinical Applications-flow cytometry and laser scanning cytometry

Cell Cycle Analysis Market traditionally carried out though the sensitive fluorescence detection methods such as flow cytometry and laser scanning cytometry. The growing awareness and the increased adoption of the cell cycle analysis instruments among the research and academic institutes has upsurged the growth of the market.

The global cell cycle analysis market is growing at a very reasonable pace. According to a recent study report published by the Market Research Future, The global cell cycle analysis market is booming and expected to gain prominence over the forecast period growing rapidly.

The market is forecasted to demonstrate a spectacular growth by 2021, surpassing its previous growth records in terms of value with a prominent CAGR during the anticipated period (2017 – 2021).

The high costs of cell analysis instruments and expensive maintenance might be a problem for small research groups and it can hamper the growth of the market during the assessment period.

Avail Sample Research Report at https://www.marketresearchfuture.com/sample_request/673

The cell cycle analysis market is expected to show a prominent growth during the forecast period (2018–2023).

Cell cycle analysis is commonly used in biomedical research studies and clinical diagnosis. It helps in distinguishing cells that are in different phases of cell cycle and used to determine the cellular response to biological stimulations and various drug.

The cell cycle analysis market is expected to grow at high growth rate due to corporate & government support in cell-based researches, high prevalence of chronic genetic diseases, growing healthcare industry and increasing medical spending, rising incidence of cancer, and technologically advancements. However, high prices of automated cell cycle analysis instruments, and reluctance among researchers to use advanced cell cycle analysis techniques may restrict the growth of this market.

Becton, Dickinson and Company (U.S.), Merck & Co., Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Danaher Corporation (U.S.), GE Healthcare (UK), Agilent Technologies, Inc. (U.S.), Olympus Corporation (Japan), PerkinElmer, Inc. (U.S.), Promega Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Miltenyi Biotech (Germany), and Nexcelom Bioscience LLC. (U.S.) are some of the prominent players at the forefront of competition in the Global Cell Cycle Analysis Market and are profiled in MRFR Analysis.

Furthermore, the instruments used in cell cycle analysis are relatively expensive, and large in size. It also requires a considerable amount of maintenance, which is less likely to be feasible for small research groups. Hence, it is difficult for the small research group to access to this equipment when required quick diagnostic results on site. Also, reluctance among researchers to use advanced cell cycle analysis techniques is another growth barrier for the market.

Intended Audience

Cell cycle analysis instrument manufacturers
Cell cycle analysis consumables manufacturers
Cell cycle analysis product distributors and suppliers
Healthcare providers and diagnostic centers
Medical device manufacturers
Research institutes and academic centers
Contract Research Organizations (CROs)
Government associations
Market research and consulting

Brows Full Detailed Report at https://www.marketresearchfuture.com/reports/cell-cycle-analysis-market-673

For instance, companies like in March 2016, Thermo Fisher has completed its anticipated acquisition of Affymetrix. This will give Thermo Fisher an expanded antibody portfolio that will strengthens its leadership in the biosciences space, as well as new genetic analysis capabilities to better serve clinical and applied markets.

Moreover, in April 2016, Genomix Nutrition also acquired San Antonio Nutrigenomic laboratory for genetic testing. This acquisition will help the company to deliver quicker test results to patients. It will also improve operational efficiencies, ensuring that the company’s nutrigenomic tests remain affordable and accessible to patients and providers.

Additionally, September 2017, Miltenyi Biotec has launched MACSQuant X – a benchtop instrument that gives you all the flexibility and is easy to use. It is a new product in field of fully automated high-throughput flow cytometry analysis.

Furthermore, in September 2016, Nexcelom Bioscience, a leading provider of cell counting and analysis products for biomedical research and the biopharma industry, has released the addition of a 5th channel available as an option on the Celigo image cytometer. This will help the company to strengthen its market share in the global market.

Therefore, the growing innovations in the field of cell cycle analysis and rising launches of various the competitive products by the major players has spurred the growth of the market.

Inquire for Discount at https://www.marketresearchfuture.com/check-discount/673

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar, Pune

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.